Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00429832 · ClinicalTrials.gov registry record · Phase 4
A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department
A Phase 4 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT00429832 is a Phase 4 study that has completed, run by University of New Mexico. The registered enrollment target is 120 participants.
The verdict
NCT00429832, a Phase 4 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
This was a trial comparing two commonly used medications for nausea and vomiting, ondansetron and promethazine, in the Emergency Department.
Interventions
- DRUG Ondansetron
- DRUG promethazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2003-10 |
| Est. Completion | 2005-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00429832
The ClinicalTrials.gov registry entry for NCT00429832 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ondansetron is the first listed.
NCT00429832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00429832 about?
NCT00429832 is a clinical study titled "A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department". This was a trial comparing two commonly used medications for nausea and vomiting, ondansetron and promethazine, in the Emergency Department.
What is the current status of trial NCT00429832?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2003-10. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00429832?
The interventions under investigation include: Ondansetron (DRUG), promethazine (DRUG).
Who is sponsoring clinical trial NCT00429832?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.